PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.53%
Positive revenue growth while CVE is negative. John Neff might see a notable competitive edge here.
-16.61%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
80.51%
Positive EBIT growth while CVE is negative. John Neff might see a substantial edge in operational management.
80.51%
Positive operating income growth while CVE is negative. John Neff might view this as a competitive edge in operations.
110.84%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
112.16%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
111.56%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.51%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.33%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-4.56%
Dividend reduction while CVE stands at 2.81%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
44.87%
OCF growth above 1.5x CVE's 7.60%. David Dodd would confirm a clear edge in underlying cash generation.
852.90%
FCF growth above 1.5x CVE's 3.68%. David Dodd would verify if the firm’s strategic investments yield superior returns.
7.54%
10Y revenue/share CAGR at 75-90% of CVE's 9.28%. Bill Ackman would press for new markets or product lines to narrow the gap.
-17.00%
Negative 5Y CAGR while CVE stands at 89.89%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
75.71%
3Y revenue/share CAGR at 50-75% of CVE's 130.13%. Martin Whitman would question if the firm lags behind competitor innovations.
54.05%
10Y OCF/share CAGR above 1.5x CVE's 21.23%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
64.42%
Below 50% of CVE's 296.59%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
73.68%
3Y OCF/share CAGR under 50% of CVE's 636.90%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
284.93%
Below 50% of CVE's 614.51%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-41.80%
Negative 5Y net income/share CAGR while CVE is 135.77%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
232.64%
3Y net income/share CAGR 50-75% of CVE's 403.68%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
9.25%
10Y equity/share CAGR at 50-75% of CVE's 15.89%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-2.49%
Negative 5Y equity/share growth while CVE is at 7.27%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
157.13%
3Y equity/share CAGR above 1.5x CVE's 7.42%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
8.84%
Stable or rising dividend while CVE is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
321.64%
5Y dividend/share CAGR above 1.5x CVE's 184.33%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
210.30%
3Y dividend/share CAGR of 210.30% while CVE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.98%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
0.44%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.12%
BV/share growth above 1.5x CVE's 0.12%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.59%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-80.31%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.